	销售和管理费用		日
Acadia Pharmaceuticals	USD 160.79M	14.06M	2026-03
Agios Pharmaceuticals	USD 38.46M	4.51M	2026-03
Alnylam Pharmaceuticals	USD 282.51M	2.55M	2026-03
BioCryst Pharmaceuticals	USD 95.78M	12.77M	2025-12
BioMarin Pharmaceutical	USD 258.28M	63.92M	2026-03
Esperion Therapeutics	USD 39.42M	456K	2025-12
Immunic	USD 3.45M	451K	2025-12
Insmed	USD 247.26M	34.78M	2026-03
Ionis Pharmaceuticals	USD 151M	21M	2026-03
Karyopharm Therapeutics	USD 9.56M	17.63M	2025-12
Kyowa Hakko Kirin	JPY 41.07B	2.82B	2026-03
MacroGenics	USD 9.71M	1.77M	2026-03
Moderna	USD 173M	135M	2026-03
Neurocrine Biosciences	USD 318.5M	16.7M	2026-03
PTC Therapeutics	USD 73.89M	13.31M	2026-03
Puma Biotechnology	USD 16.82M	8.15M	2024-09
Regeneron Pharmaceuticals	USD 647.7M	127.3M	2026-03
Sarepta Therapeutics	USD 54.03M	51.35M	2026-03
Ultragenyx Pharmaceutical	USD 88M	1000K	2026-03
Vertex Pharmaceuticals	USD 493.7M	6.7M	2026-03
Xoma	USD 11M	2.54M	2024-06